![Jared Gollob](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jared Gollob
Nessuna posizione attualmente
Patrimonio netto: 8 M $ in data 30/06/2026
Profilo
Jared Gollob worked at Duke University from 2002 to 2007 as Director of the Biologic Therapy Program.
From 2007 to 2018, worked at Alnylam Pharmaceuticals, Inc., serving as Global VP of Medical Affairs and Clinical Development from 2012 to 2018.
From 2018 to 2026, worked at Kymera Therapeutics, Inc. as Chief Medical Officer.
Former jobs include Director-Biologic Therapy Program at Duke University and Global VP-Medical Affairs & Clinical Development at Alnylam Pharmaceuticals, Inc.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 71.359 ( 0,09% ) | 8 M $ | 30/06/2026 |
Precedenti posizioni note di Jared Gollob
| Società | Posizione | Fine |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 27/07/2026 |
| ALNYLAM PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/08/2018 |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/09/2007 |
Formazione di Jared Gollob
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
92
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
